Volume | 350,488 |
|
|||||
News | (1) | ||||||
Day High | 224.35 | Low High |
|||||
Day Low | 219.63 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Teleflex Inc | TFX | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
220.78 | 219.63 | 224.35 | 221.25 | 219.83 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
12,084 | 350,488 | $ 222.62 | $ 78,026,977 | - | 177.633 - 276.43 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
18:30:00 | 40,256 | $ 221.25 | USD |
Teleflex Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
10.4B | 46.99M | - | 2.8B | 363.14M | 7.73 | 28.64 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Teleflex News
Loading Messages....
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical TFX Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 218.51 | 224.35 | 216.33 | 219.30 | 176,170 | 2.74 | 1.25% |
1 Month | 185.25 | 224.35 | 183.9089 | 206.96 | 334,155 | 36.00 | 19.43% |
3 Months | 208.47 | 224.35 | 177.633 | 201.57 | 303,982 | 12.78 | 6.13% |
6 Months | 232.29 | 262.97 | 177.633 | 220.47 | 295,799 | -11.04 | -4.75% |
1 Year | 224.84 | 276.43 | 177.633 | 233.98 | 316,497 | -3.59 | -1.6% |
3 Years | 371.95 | 449.375 | 177.633 | 290.90 | 320,109 | -150.70 | -40.52% |
5 Years | 266.09 | 449.375 | 177.633 | 302.38 | 303,721 | -44.84 | -16.85% |
Teleflex Description
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (25% of 2021 sales), interventional (15%), anesthesia (14%), surgical (13%), interventional urology (12%), original-equipment manufacturing (9%), and all other (12%). Geographic exposure for the business is primarily in the U.S., which accounts for 60% of revenue, with international markets making up the remainder. |